Example: Heart Attack

Search clinical trials for: Halofuginone

Total 5 results





    • NCT02525302
      Terminated
      HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02
      Conditions: Duchenne Muscular Dystrophy
    • NCT01978366
      Terminated
      Open Label Extension Study of HT-100 in Patients With DMD
      Conditions: Duchenne Muscular Dystrophy
    • NCT01847573
      Terminated
      Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy
      Conditions: Duchenne Muscular Dystrophy
    • NCT00064142
      Completed
      Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
      Conditions: AIDS-related Kaposi Sarcoma; Recurrent Kaposi Sarcoma
    • NCT00027677
      Completed
      Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
      Conditions: Unspecified Adult Solid Tumor, Protocol Specific
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations